Literature DB >> 2436227

Activation of pp60c-src protein kinase activity in human colon carcinoma.

J B Bolen, A Veillette, A M Schwartz, V DeSeau, N Rosen.   

Abstract

The tyrosine-specific protein kinase activity of pp60c-src molecules obtained from human colon carcinoma tissues and tumor-derived cell lines was found to be elevated over that from normal colon tissues or cultures of normal colon mucosal cells. The elevated pp60c-src protein kinase activity in tumor tissues and in cultured colon carcinoma cells does not appear to result solely from an increase in the abundance of the c-src-encoded protein, suggesting that the specific activity of the pp60c-src tyrosine phosphotransferase is enhanced. These results raise the possibility that activation of the pp60c-src protein kinase may contribute to the genesis of human colon tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436227      PMCID: PMC304627          DOI: 10.1073/pnas.84.8.2251

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src.

Authors:  H Iba; F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

Review 2.  Viral oncogenes.

Authors:  J M Bishop
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

Review 3.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Stimulation of pp60c-src tyrosyl kinase activity in polyoma virus-infected mouse cells is closely associated with polyoma middle tumor antigen synthesis.

Authors:  J B Bolen; A M Lewis; M A Israel
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

5.  Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.

Authors:  A Thor; P Horan Hand; D Wunderlich; A Caruso; R Muraro; J Schlom
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

6.  Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene.

Authors:  M S McCoy; C I Bargmann; R A Weinberg
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

7.  Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations.

Authors:  J G Collard; W P van Beek; J W Janssen; J F Schijven
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

8.  Expression of p21ras in fresh primary and metastatic human colorectal tumors.

Authors:  G E Gallick; R Kurzrock; W S Kloetzer; R B Arlinghaus; J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells.

Authors:  S Amini; V DeSeau; S Reddy; D Shalloway; J B Bolen
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

10.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  70 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 2.  Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging.

Authors:  Alan Serrels; Marta Canel; Valerie G Brunton; Margaret C Frame
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

3.  Pervanadate stabilizes desmosomes.

Authors:  David R Garrod; Christal Fisher; Angela Smith; Zhuxiang Nie
Journal:  Cell Adh Migr       Date:  2008-07-03       Impact factor: 3.405

4.  Functional development of Src tyrosine kinases during evolution from a unicellular ancestor to multicellular animals.

Authors:  Yuko Segawa; Hiroshi Suga; Naoyuki Iwabe; Chitose Oneyama; Tsuyoshi Akagi; Takashi Miyata; Masato Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

5.  Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.

Authors:  John H Strickler; Shannon McCall; Andrew B Nixon; John C Brady; Herbert Pang; Christel Rushing; Allen Cohn; Alexander Starodub; Christy Arrowood; Sherri Haley; Kellen L Meadows; Michael A Morse; Hope E Uronis; Gerard C Blobe; S David Hsu; S Yousuf Zafar; Herbert I Hurwitz
Journal:  Invest New Drugs       Date:  2013-11-01       Impact factor: 3.850

6.  The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src.

Authors:  A C Guappone; D C Flynn
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

7.  pp60v-src transformation of rat cells but not chicken cells strongly correlates with low-affinity phosphopeptide binding by the SH2 domain.

Authors:  M F Verderame
Journal:  Mol Biol Cell       Date:  1997-05       Impact factor: 4.138

8.  Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.

Authors:  S Markowitz; M Haut; T Stellato; C Gerbic; K Molkentin
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice.

Authors:  T Katagiri; J P Ting; R Dy; C Prokop; P Cohen; H S Earp
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

10.  Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.

Authors:  Renee D Read; Erika A Bach; Ross L Cagan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.